礼来Eli Lilly & Co. (LLY) 2010年年度报告「NYSE」.pdf

1、G e t t i n g T h e r eEli Lilly and Company 2010 Annual ReportNotice of 2011 Annual MeetingProxy StatementYear in Review 1 Financial Highlights 2 Letter to Shareholders 7 Pipeline of Molecules in Clinical DevelopmentForm 10-K 2 Products 17 Results of Operations 34 Consolidated Statements of Operati

2、ons 35 Consolidated Balance Sheets 36 Consolidated Statements of Cash Flows 37 Consolidated Statements of Comprehensive Income(Loss)38 Segment Information 39 Selected Quarterly Data 40 Selected Financial Data 42 Notes to Consolidated Financial Statements 73 Managements Reports 74 Reports of Independ

3、ent Registered Public Accounting FirmFor more information on Lillys commitment to corporate responsibility,please see the inside back cover of this report.The Lilly PromiseOur MissionLilly makes medicines that help people live longer,healthier,more active lives.Our ValuesIntegrity|Excellence|Respect

4、 for PeopleWe promise to operate our business with absolute integrity and earn the trust of all,set the highest standards for our performance and for the performance of our products,and demonstrate caring and respect for all those who share in our mission and are touched by our work.Our VisionWe wil

5、l make a significant contribution to humanity by improving global health in the 21st century.Starting with the work of our scientists,we will place improved outcomes for individual patients at the center of what we do.We will listen carefully to understand patient needs and work with health care par

6、tners to provide meaningful benefits for the people who depend on us.Our StrategyWe will create value for all our stakeholders by accel-erating the flow of innovative medicines that provide improved outcomes for individual patients.Getting There The path to Lillys future is a pipeline,and a bridge.T